Drug Profile
Research programme: hyaluronan-linked therapeutics - Meditech/Griffith University
Alternative Names: Hyaluronic acid-linked therapeutics - Meditech/Griffith UniversityLatest Information Update: 07 May 2010
Price :
$50
*
At a glance
- Originator Griffith University; Meditech Research
- Class
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Cancer; Skin disorders
Most Recent Events
- 07 May 2010 Discontinued - Preclinical for Cancer in Australia (IV)
- 07 May 2010 Discontinued - Preclinical for Skin disorders in Australia (Topical)
- 12 Nov 2004 Preclinical trials in Cancer in Australia (IV)